Search
from www.Drugpatentwatch.com / Copyright 2002-2017
- 2 min
Globalization in the pharmaceutical industry
Where are drugs invented, and how can easily innovation be seeded in new areas? This is the first of DrugPatentWatch's publications profiling the locations of pharmaceutical innovation.
The location of drug development is important for two reasons. Firstly, it is important to track the global spread of innovation. Much late stage drug development (e.g. clinical trials) and manufacturing have moved to lower wage-cost countries, but trends in the location of invention has not
David Kroll on www.forbes.com
- 4 min
Why Biosimilar Drug Names Contain Unhelpful Gibberish
Have you ever wondered how drugs are named? Is there ever a discernible meaning behind drug names? Who manages this mess anyway–drug companies, the FDA or perhaps some toddler with magnetic letters on a refrigerator? Earlier this year, the FDA released its final rule (PDF here) on how companies should name biosimilar drugs–the large protein molecules that have gone off patent and are made by an entity other than the innovator (the original drug developer). In this case, the a
